Novartis: Strong Execution With A P/E Discount

Group 1 - The article suggests increasing the position in Novartis due to positive momentum, with the stock price rising nearly 10% since mid-December 2024 [1] - The analysis indicates that buy-side hedge professionals are conducting fundamental, income-oriented, long-term analysis across various sectors in developed markets [1] Group 2 - The author has a beneficial long position in Novartis shares, indicating a personal investment interest [2]